Showing 2977 results
-
Press release /Key data from PSMAddition has been selected for a Presidential session; data to showcase the efficacy and safety of PluvictoTM plus standard of care (SoC) versus SoC alone in PSMA+ mHSPCNATALEE five-…
-
Event / Sep 24, 2025At this year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting, we will be sharing the latest data and research from our neuroscience portfolio, driven by…
-
Press release /ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after…
-
Press release /Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular diseasePacibekitug is a…
-
Story / -
Event / Sep 17, 2025